Wells Fargo analyst Joe Quatrochi upgraded Analog Devices, Inc. (ADI) to an “Overweight” rating while adjusting the firm’s price target for the stock to $340, up from a previous consensus of $301.25.
On January 15, 2026, Barclays analyst Tom O’Malley upgraded Applied Materials, Inc. (AMAT) to an Overweight rating. This new assessment comes with a price target increase to $360, suggesting ...
Albertsons Companies, Inc. (NYSE: ACI) has recently been downgraded to an Underweight rating by Simeon Gutman of Morgan Stanley, a significant shift that reflects growing investor caution toward the ...
Kazuya Nishimura is an analyst from Daiwa Capital specializing in the Financial Services sector. They are beginning to establish their track record, with 2 stock rating s so far. Their current stats ...
Essex Property Trust, Inc. (ESS) received a “Market Perform” rating from John Kim at BMO Capital on January 9, 2026, a ...
Summary • Arbe Robotics Ltd. (ARBE) rises 15% in pre-market trading, reaching $1.38 after CES 2026 showcasing. • The company ...
Summary • CeriBell, Inc. (CBLL) jumps 23% in pre-market trading following FDA Breakthrough Device Designation for a stroke ...
HealthEquity, Inc. (HQY) has recently been downgraded to a “Sell” rating by David Roman of Goldman Sachs, with a price target slashed to $89 from earlier estimates. This change comes at a time when ...
Equity Residential (NYSE: EQR) has recently been assigned a “Market Perform” rating by analyst John Kim from BMO Capital, reflecting a cautious outlook for investors amid mixed performance indicators.
MoonLake Immunotherapeutics (MLTX) is garnering attention in the investment community following a recent upgrade to a Buy rating from BTIG analyst Julian Harrison. This bullish outlook comes with a ...
Cleveland-Cliffs Inc. (CLF) has recently been upgraded to an Overweight rating by Carlos De Alba of Morgan Stanley, a change that could signal a positive outlook for investors. The new price target of ...
In a recent note, BMO Capital analyst Juan Sanabria assigned a “Market Perform” rating to Omega Healthcare Investors, Inc. (NYSE: OHI), indicating a cautious stance on the stock despite a slightly ...